Patents by Inventor Ricardo Resende

Ricardo Resende has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9949945
    Abstract: Equatorial 2,3-fluorinated glycosides compounds of formula (I) useful for the treatment or prophylaxis of viral infection, particularly viral influenza, the methods for their preparation, and their pharmaceutical compositions are provided. The therapeutic effect is achieved via inhibition of viral neuraminidases.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: April 24, 2018
    Assignee: The University of British Columbia
    Inventors: Stephen Withers, Hongming Chen, Ricardo Resende, Jennifer Lois Breschkin
  • Publication number: 20170165223
    Abstract: Equatorial 2,3-fluorinated glycosides compounds of formula (I) useful for the treatment or prophylaxis of viral infection, particularly viral influenza, the methods for their preparation, and their pharmaceutical compositions. The therapeutic effect is achieved via inhibition of viral neuraminidases.
    Type: Application
    Filed: August 22, 2016
    Publication date: June 15, 2017
    Inventors: Stephen Withers, Hongming Chen, Ricardo Resende, Jennifer Lois Breschkin
  • Patent number: 9637465
    Abstract: Equatorial 2,3-fluorinated glycosides compounds of formula (I) useful for the treatment or prophylaxis of viral infection, particularly viral influenza, the methods for their preparation, and their pharmaceutical compositions. The therapeutic effect is achieved via inhibition of viral neuraminidases.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: May 2, 2017
    Assignee: The University of British Columbia
    Inventors: Stephen Withers, Hongming Chen, Ricardo Resende, Jennifer Lois Breschkin
  • Publication number: 20140350095
    Abstract: Equatorial 2,3-fluorinated glycosides compounds of formula (I) useful for the treatment or prophylaxis of viral infection, particularly viral influenza, the methods for their preparation, and their pharmaceutical compositions. The therapeutic effect is achieved via inhibition of viral neuraminidases.
    Type: Application
    Filed: January 17, 2013
    Publication date: November 27, 2014
    Inventors: Stephen Withers, Hongming Chen, Ricardo Resende, Jennifer Lois Breschkin